News
Pfizer stock is incredibly cheap following management's raise of its 2025 adjusted earnings per share guidance. It's at just ...
Chicago, IL – August 12, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks ...
Royalty Pharma Plc (NASDAQ:RPRX) is one of the top most undervalued biotech stocks to buy now. In a report released on August ...
Public health experts noted that the coronavirus is still a threat, even for otherwise healthy children younger than 2.
Cambridge based drug sleuth Bicycle Therapeutics has extended its cash runway from mid-2027 into 2028 as it closes in on ...
Total revenues of €97.6 million compared to €70.8 million in the first half of 2024Cash and cash equivalents of €161.3 million at end of June 2025Further clinical and regulatory progress2025 financial ...
Pfizer (PFE) stock and BioNTech (BNTX) stock in focus as FDA may not renew the authorization for their pediatric COVID shot. Read more here.
17hon MSN
Pfizer, Astellas post late-stage trial win for Padcev with Merck’s Keytruda in bladder cancer
Pfizer (NYSE:PFE) and Astellas Pharma (OTCPK:ALPMF) announced on Tuesday that their jointly developed antibody-drug conjugate ...
Indian equity benchmarks closed lower in a volatile Tuesday session, weighed down by blue-chip bank stocks and caution ahead ...
Pfizer Inc. reported groundbreaking results in its recent Phase 3 study. **The study showcased HYMPAVZI, reducing bleeding rates by 93% compared to traditional treatments.** This once-weekly ...
10h
Barchart on MSNWhy Acher Aviation (ACHR) Post-Earning’s Tailspin Looks Like a Favorably Mispriced Opportunity
While air mobility specialist Archer Aviation (ACHR) had been on a wild ride this year, the wheels started to fall off last ...
Blackstone shares rose 0.69% on impressive Q2 results.** Revenue soared 43% reaching $3.8 billion, while net income jumped 72 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results